Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

41. Self-management plans for COPD in low and middle income countries: evidence and implications

Self-management plans for COPD in low and middle income countries: evidence and implications Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

42. Epigenetic modifications purely associated with COPD a systematic review

Epigenetic modifications purely associated with COPD a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

43. Efficacy and safety among LAMA / LABA in stable COPD patients: a systematic review and network meta-analysis

Efficacy and safety among LAMA / LABA in stable COPD patients: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

44. Efficacy and safety among ICS / LAMA / LABA therapies in stable COPD patients: a systematic review and network meta-analysis

Efficacy and safety among ICS / LAMA / LABA therapies in stable COPD patients: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

45. A systematic review on the effectiveness of community-based non-pharmacological interventions to improve the health-related quality of life among people with chronic obstructive pulmonary disease (COPD)

A systematic review on the effectiveness of community-based non-pharmacological interventions to improve the health-related quality of life among people with chronic obstructive pulmonary disease (COPD) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

46. Efficacy of low molecular weight heparin (LMWH) for chronic obstructive pulmonary disease (COPD) and respiratory failure (RF): a systematic review protocol of randomized controlled trials

Efficacy of low molecular weight heparin (LMWH) for chronic obstructive pulmonary disease (COPD) and respiratory failure (RF): a systematic review protocol of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

47. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) [Cochrane protocol]

Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

48. Biomarkers to guide antibiotic therapy for COPD exacerbations [Cochrane protocol]

Biomarkers to guide antibiotic therapy for COPD exacerbations [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

49. The correlation between altitude and the prevalence of COPD: a systematic review and meta-analysis

The correlation between altitude and the prevalence of COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

50. Effects of telehealth care on chronic obstructive pulmonary disease (COPD) patients with different disease severity and economic development levels: a systematic review and meta-analysis

Effects of telehealth care on chronic obstructive pulmonary disease (COPD) patients with different disease severity and economic development levels: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

51. COPD in sub-Saharan Africa: a systematic review and meta-analysis

COPD in sub-Saharan Africa: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

52. Telehealthcare for remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD) [Cochrane protocol]

Telehealthcare for remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD) [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

53. Systematic review and meta-analysis of dementia risk with COPD patients

Systematic review and meta-analysis of dementia risk with COPD patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

54. Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

55. Prevalence and baseline clinical characteristics of eosinophilic COPD

Prevalence and baseline clinical characteristics of eosinophilic COPD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

56. Association between outdoor PM2.5 and prevalence of COPD: a systematic review and meta-analysis

Association between outdoor PM2.5 and prevalence of COPD: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

57. Impact of nurse-led intervention in pulmonary rehabilitation programmes on the capacity for self care of the person with COPD

Impact of nurse-led intervention in pulmonary rehabilitation programmes on the capacity for self care of the person with COPD Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

58. Efficacy and safety of Revefenacin in treatment of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis

Efficacy and safety of Revefenacin in treatment of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

59. Characteristics of aerobic exercise programs used in people with COPD: a systematic review

Characteristics of aerobic exercise programs used in people with COPD: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

60. Can serum uric acid be used as a biomarker for COPD? A meta-analysis

Can serum uric acid be used as a biomarker for COPD? A meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO